LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification
0
🏷️
Sign in to get full access
Overview
- Machine learning is being used to analyze changes in gene expression patterns and improve our understanding of cancer.
- Combining different types of genetic data (multi-omics data) can enhance cancer classification.
- Effectively integrating and understanding the complex relationships in multi-omics data remains challenging.
Plain English Explanation
The paper introduces a new graph-based deep learning framework called LASSO-MOGAT that combines three types of genetic data - messenger RNA, microRNA, and DNA methylation - to classify 31 different cancer types.
The key steps are:
- Using statistical methods to identify important genes and features from the genetic data.
- Representing the relationships between these genes using a protein-protein interaction network.
- Feeding this network into a graph attention model to capture the complex interactions between the different layers of genetic data.
This approach allows the model to find subtle connections in the data that improve its ability to accurately classify different cancer types. The model's "attention" mechanism also helps identify the key genetic factors driving cancer development.
Technical Explanation
The paper utilizes a graph-based deep learning framework called LASSO-MOGAT to integrate messenger RNA, microRNA, and DNA methylation data for cancer classification.
First, differential expression analysis and LASSO regression are used to select informative features from the multi-omics data. Then, a Graph Attention Network (GAT) is leveraged to incorporate a protein-protein interaction network and capture complex relationships within the data.
The GAT model computes attention coefficients for the edges in the protein interaction graph, allowing it to identify synergistic interactions across the different omics layers that are most relevant for cancer classification. This attention mechanism provides interpretable insights into the key molecular drivers of cancer.
Experimental validation using 5-fold cross-validation demonstrates the precision, reliability, and comprehensiveness of the LASSO-MOGAT approach for cancer subtype classification.
Critical Analysis
The paper provides a robust and innovative framework for integrating multi-omics data to enhance cancer research. The use of graph attention networks is a promising approach for uncovering complex relationships in high-dimensional biological data.
However, the research is limited to 31 cancer types, and further validation on larger and more diverse cancer datasets would help assess the generalizability of the method. Additionally, the paper does not extensively discuss potential challenges in obtaining and preprocessing the required multi-omics data in practice.
While the attention mechanism offers interpretability, more work may be needed to fully elucidate the biological significance of the identified gene interactions and their roles in cancer pathogenesis.
Conclusion
This research demonstrates the power of combining machine learning with multi-omics data analysis to advance our understanding of cancer. The LASSO-MOGAT framework provides an effective way to integrate diverse genetic information and uncover the complex molecular underpinnings of cancer.
By leveraging graph attention networks, this work offers important insights that could guide future cancer research and the development of more personalized diagnostic and therapeutic approaches.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🏷️
0
LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification
Fadi Alharbi, Aleksandar Vakanski, Murtada K. Elbashir, Mohanad Mohammed
The application of machine learning methods to analyze changes in gene expression patterns has recently emerged as a powerful approach in cancer research, enhancing our understanding of the molecular mechanisms underpinning cancer development and progression. Combining gene expression data with other types of omics data has been reported by numerous works to improve cancer classification outcomes. Despite these advances, effectively integrating high-dimensional multi-omics data and capturing the complex relationships across different biological layers remains challenging. This paper introduces LASSO-MOGAT (LASSO-Multi-Omics Gated ATtention), a novel graph-based deep learning framework that integrates messenger RNA, microRNA, and DNA methylation data to classify 31 cancer types. Utilizing differential expression analysis with LIMMA and LASSO regression for feature selection, and leveraging Graph Attention Networks (GATs) to incorporate protein-protein interaction (PPI) networks, LASSO-MOGAT effectively captures intricate relationships within multi-omics data. Experimental validation using five-fold cross-validation demonstrates the method's precision, reliability, and capacity for providing comprehensive insights into cancer molecular mechanisms. The computation of attention coefficients for the edges in the graph by the proposed graph-attention architecture based on protein-protein interactions proved beneficial for identifying synergies in multi-omics data for cancer classification.
Read more9/2/2024
0
Heterogeneous graph attention network improves cancer multiomics integration
Sina Tabakhi, Charlotte Vandermeulen, Ian Sudbery, Haiping Lu
The increase in high-dimensional multiomics data demands advanced integration models to capture the complexity of human diseases. Graph-based deep learning integration models, despite their promise, struggle with small patient cohorts and high-dimensional features, often applying independent feature selection without modeling relationships among omics. Furthermore, conventional graph-based omics models focus on homogeneous graphs, lacking multiple types of nodes and edges to capture diverse structures. We introduce a Heterogeneous Graph ATtention network for omics integration (HeteroGATomics) to improve cancer diagnosis. HeteroGATomics performs joint feature selection through a multi-agent system, creating dedicated networks of feature and patient similarity for each omic modality. These networks are then combined into one heterogeneous graph for learning holistic omic-specific representations and integrating predictions across modalities. Experiments on three cancer multiomics datasets demonstrate HeteroGATomics' superior performance in cancer diagnosis. Moreover, HeteroGATomics enhances interpretability by identifying important biomarkers contributing to the diagnosis outcomes.
Read more8/7/2024
0
Graph Representation Learning Strategies for Omics Data: A Case Study on Parkinson's Disease
Elisa G'omez de Lope (University of Luxembourg), Saurabh Deshpande (University of Luxembourg), Ram'on Vi~nas Torn'e ('Ecole polytechnique f'ed'erale de Lausanne), Pietro Li`o (University of Cambridge), Enrico Glaab (University of Luxembourg, On behalf of the NCER-PD Consortium), St'ephane P. A. Bordas (University of Luxembourg)
Omics data analysis is crucial for studying complex diseases, but its high dimensionality and heterogeneity challenge classical statistical and machine learning methods. Graph neural networks have emerged as promising alternatives, yet the optimal strategies for their design and optimization in real-world biomedical challenges remain unclear. This study evaluates various graph representation learning models for case-control classification using high-throughput biological data from Parkinson's disease and control samples. We compare topologies derived from sample similarity networks and molecular interaction networks, including protein-protein and metabolite-metabolite interactions (PPI, MMI). Graph Convolutional Network (GCNs), Chebyshev spectral graph convolution (ChebyNet), and Graph Attention Network (GAT), are evaluated alongside advanced architectures like graph transformers, the graph U-net, and simpler models like multilayer perceptron (MLP). These models are systematically applied to transcriptomics and metabolomics data independently. Our comparative analysis highlights the benefits and limitations of various architectures in extracting patterns from omics data, paving the way for more accurate and interpretable models in biomedical research.
Read more6/21/2024
🔮
0
Stacked ensemble-based mutagenicity prediction model using multiple modalities with graph attention network
Tanya Liyaqat, Tanvir Ahmad, Mohammad Kashif, Chandni Saxena
Mutagenicity is a concern due to its association with genetic mutations which can result in a variety of negative consequences, including the development of cancer. Earlier identification of mutagenic compounds in the drug development process is therefore crucial for preventing the progression of unsafe candidates and reducing development costs. While computational techniques, especially machine learning models have become increasingly prevalent for this endpoint, they rely on a single modality. In this work, we introduce a novel stacked ensemble based mutagenicity prediction model which incorporate multiple modalities such as simplified molecular input line entry system (SMILES) and molecular graph. These modalities capture diverse information about molecules such as substructural, physicochemical, geometrical and topological. To derive substructural, geometrical and physicochemical information, we use SMILES, while topological information is extracted through a graph attention network (GAT) via molecular graph. Our model uses a stacked ensemble of machine learning classifiers to make predictions using these multiple features. We employ the explainable artificial intelligence (XAI) technique SHAP (Shapley Additive Explanations) to determine the significance of each classifier and the most relevant features in the prediction. We demonstrate that our method surpasses SOTA methods on two standard datasets across various metrics. Notably, we achieve an area under the curve of 95.21% on the Hansen benchmark dataset, affirming the efficacy of our method in predicting mutagenicity. We believe that this research will captivate the interest of both clinicians and computational biologists engaged in translational research.
Read more9/6/2024